IMMUNOLOGY2026™: Day 3

The Immunology Podcast23mApril 18, 2026

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “IMMUNOLOGY2026™: Day 3” inside PodZeus.

AI-Generated Summary

In this special episode of The Immunology Podcast, Dr. Jason Goldsmith and Dr. Brenda Rout recap Day 3 of Immunology 2026 in Boston, highlighting groundbreaking research on the intersection of metabolism, immunity, and disease. Key themes include how dietary fats—particularly animal fats like butter—impair T-cell function through lipid remodeling, mitochondrial dysfunction, and accumulation of long-chain acyl carnitines, while cholesterol plays a critical role in exacerbating immune exhaustion and inflammation. The episode also explores how neutrophils use lipid-specific signaling via TLRs to alter actin dynamics and contribute to atherosclerosis, and how ketogenic diets and bacterial ceramides enhance cutaneous wound healing via gamma-delta T cells and IL-1 signaling. A major focus is on the microbiome’s role in immune regulation, with studies showing that microbial tryptophan metabolites (like indole lactate) suppress pathogenic TH17 cells in multiple sclerosis, suggesting therapeutic potential for ketogenic diets and supplements like 13BD. The hosts also spotlight two standout talks: Brandon Dikowski’s work on engineering broadly neutralizing antibodies against malaria through multi-axis Fab-Fab interactions, and David Masipist’s research on expanding human tissue-resident memory T cells for use in 'peptide alarm therapy' to convert cold tumors into hot ones. These advances underscore the growing power of synthetic immunology and metabolic reprogramming in next-generation therapies.

Key Takeaways
1

Animal fats like butter impair T-cell function by causing lipid remodeling, mitochondrial dysfunction, and accumulation of long-chain acyl carnitines, leading to immune exhaustion.

2

Cholesterol and specific lipid classes are essential for driving T-cell dysfunction and inflammation, highlighting a dual role in metabolic and immune pathology.

3

Ketogenic diets and microbial metabolites (e.g., indole lactate) suppress pathogenic TH17 cells and may offer therapeutic benefits in autoimmune diseases like multiple sclerosis.

4

Engineered antibodies with multi-axis Fab-Fab interactions can neutralize diverse variants of malaria’s CSP protein, offering a new path for broadly protective vaccines.

5

Tissue-resident memory T cells from human donors can be expanded in culture for over a year, enabling new strategies like 'peptide alarm therapy' to activate anti-tumor immunity.

Chapters
0:00
2 min

Welcome & Conference Recap

Hosts Dr. Jason Goldsmith and Dr. Brenda Rout welcome listeners to Day 3 of Immunology 2026, highlighting the live podcast recording and upcoming episode on solid tumor immunotherapy. They encourage followers to engage via social media and revisit earlier recaps.

2:00
3 min

Obesity, Lipids, and Immune Exhaustion

Sucky T cells plus inflammation is cancer.

Highlight
5:00
3 min

Neutrophil Metabolism and Atherosclerosis

Emily Goldberg reveals that neutrophil lipid uptake is TLR-regulated and alters actin dynamics, contributing to atherosclerotic plaque formation. Neutrophils, though short-lived, play a significant role in chronic inflammation.

8:00
3 min

Microbiome, Diet, and Wound Healing

Motoyoshi Nagai shows that ketogenic diets and Staphylococcus epidermidis enhance cutaneous wound healing via gamma-delta T cells and IL-1 signaling, with bacterial ceramides playing a critical role in immune modulation.

11:00
3 min

Microbiome and Oral Tolerance

Maria Cecilia Campos Caneso presents the 'lipstick' method to track antigen-presenting cell–T cell interactions, showing that bacterial presentation in the gut induces Tregs and tolerance via DC1/DC2 switching.

High-Impact Quotes
This is something that he has never, it has never been reported on like natural antibodies. This is a consequence of the mutations that he introduced in this antibody to make it better at neutralizing this protein.
Dr. Brenda Rout16:26
Viral: 90.0
What if we have a tumor? We know for a fact that inside that tumor there's going to be T cells... specific from a previous viral infection that this person had. What if we activate the cells?
Dr. Brenda Rout20:10
Viral: 88.0
Sucky T cells plus inflammation is cancer.
Dr. Brenda Rout5:29
Viral: 85.0
Speakers

Hosts

Dr. Jason GoldsmithDr. Brenda Rout

Guests

Dr. Charles SentmanJulia EscobarLydia LynchEmily GoldbergMotoyoshi NagaiMaria Cecilia Campos CanesoKate StacksBrandon DikowskiDavid Masipist
Topics Discussed
T Cell Metabolism and Exhaustion95%Peptide Alarm Therapy92%Diet and Immune Function90%Antibody Engineering and Affinity Maturation88%Tissue-Resident Memory T Cells87%Microbiome and Immune Regulation85%Lipid Signaling in Inflammation83%Metabolic Reprogramming in Autoimmunity80%
People & Brands

Dr. Jason Goldsmith

person

15xPositive

Dr. Brenda Rout

person

14xPositive

Multiple Sclerosis

other

4xPositive

Malaria

other

4xNeutral

Lydia Lynch

person

3xPositive

David Masipist

person

3xPositive

Lactobacillus

other

3xPositive

Kate Stacks

person

3xPositive

Brandon Dikowski

person

3xPositive

Motoyoshi Nagai

person

2xPositive

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “IMMUNOLOGY2026™: Day 3” inside PodZeus.

Start discovering podcast insights today

Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.

No credit card required • 7-day trial • Cancel anytime